Disease-specific survival for limited-stage small-cell lung cancer affected by statistical method of assessment

BMC Cancer

Table 1 Patient characteristics (N = 244)

Total number of patients	244
Sex:
Male	144
Female	100
Age: median	63.72 (range: 38.4–82.0)
Surgery:
Complete	14
Partial	3
no surgery	227
ECOG Performance Status:
0	75
1	150
2	11
3	5
4	3
Weight loss:
> 5%	164
Unknown	21
Hemoglobin:
Male	128 low, 6 normal, 10 unknown
Female	66 low, 26 normal, 8 unknown
Chemotherapy cycles: median	6 (range: 0 – 27)
Chest Biological Effective Dose: median	46.9 Gy₁₀ (range: 22.6–66.1)

Gy₁₀, biologically effective doses calculated using the linear-quadratic formula using an α/β = 10 for tumor tissue.

ISSN: 1471-2407